rs387906364
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000492.4(CFTR):c.429del(p.Phe143LeufsTer10) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,514 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★★). Synonymous variant affecting the same amino acid position (i.e. I142I) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000492.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.429del | p.Phe143LeufsTer10 | frameshift_variant | 4/27 | ENST00000003084.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFTR | ENST00000003084.11 | c.429del | p.Phe143LeufsTer10 | frameshift_variant | 4/27 | 1 | NM_000492.4 | P2 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461514Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727030
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 24, 2020 | Variant summary: CFTR c.429delT (p.Phe143LeufsX10) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 250646 control chromosomes (gnomAD). c.429delT (also known as 557delT) has been reported in the literature in multiple individuals affected with Cystic Fibrosis (e.g. Schwarz_1995, Hughes_1996, McCague_2019). These data indicate that the variant is very likely to be associated with disease. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, reviewed by expert panel | research | CFTR2 | Jul 31, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Oct 19, 2018 | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CFTR are known to be pathogenic (PMID: 1695717, 7691345, 9725922). This variant has been observed in an individual affected with cystic fibrosis (PMID: 1374052). This variant is also known as 557delT in the literature. ClinVar contains an entry for this variant (Variation ID: 7147). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Phe143Leufs*10) in the CFTR gene. It is expected to result in an absent or disrupted protein product. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 1992 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2015 | The c.429delT pathogenic mutation is located in coding exon 4 of the CFTR gene, results from a deletion of one nucleotide at position 429, causing a translational frameshift with a predicted alternate stop codon. This pathogenic mutation was described in a patient with elevated sweat chloride levels, pancreatic insufficiency, and mild pulmonary involvement (Graham CA et al. Genomics 1992;12:854). In addition to the clinical data presented in the literature, since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). - |
CFTR-related disorders Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 17, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at